D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$339M |
| 2 |
James River Group Holdings
JRVR
|
+$309M |
| 3 |
Phillips 66
PSX
|
+$252M |
| 4 |
LyondellBasell Industries
LYB
|
+$251M |
| 5 |
DuPont de Nemours
DD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
Alibaba
BABA
|
+$408M |
| 3 |
Booking.com
BKNG
|
+$406M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$284M |
| 5 |
Micron Technology
MU
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Consumer Discretionary | 8.11% |
| 3 | Energy | 8.03% |
| 4 | Healthcare | 6.93% |
| 5 | Communication Services | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NRF
3676
CALL
DELISTED
NorthStar Realty Finance Corp.
NRF
| $264K | ﹤0.01% |
7,500
| – | – |
|
|
VRNG
3677
DELISTED
VRINGO, INC COM STK NEW (DE)
VRNG
| $262K | ﹤0.01% |
+47,697
| New | +$404K |
|
|
ASRT
3678
CALL
DELISTED
Assertio
ASRT
| $261K | ﹤0.01% |
270
| – | – |
|
3679
Flowserve
FLS
$9.25B
| $261K | ﹤0.01% |
+4,367
| New | +$278K |
|
3680
Galectin Therapeutics
GALT
$229M
| $261K | ﹤0.01% |
+75,182
| New | +$332K |
|
3681
KT
KT
$8.84B
| $259K | ﹤0.01% |
18,368
-37,838
| -67% | -$563K |
|
|
OPB
3682
DELISTED
Opus Bank Common Stock
OPB
| $259K | ﹤0.01% |
9,123
-6,542
| -42% | -$183K |
|
3683
CALL
D.R. Horton
DHI
$41B
| $255K | ﹤0.01% |
10,100
-20,000
| -66% | -$468K |
|
3684
CALL
Genworth Financial
GNW
$3.8B
| $255K | ﹤0.01% |
30,000
-41,500
| -58% | -$436K |
|
|
HWCC
3685
DELISTED
Houston Wire & Cable Company
HWCC
| $255K | ﹤0.01% |
21,363
+3,417
| +19% | +$42.9K |
|
|
REXX
3686
PUT
DELISTED
Rex Energy Corporation
REXX
| $255K | ﹤0.01% |
5,000
-6,930
| -58% | -$532K |
|
3687
PTC Therapeutics
PTCT
$6.37B
| $253K | ﹤0.01% |
+4,885
| New | +$215K |
|
|
PSUN
3688
DELISTED
PACIFIC SUNWEAR OF CAL. INC
PSUN
| $252K | ﹤0.01% |
115,566
+44,286
| +62% | +$77.2K |
|
3689
PUT
First Majestic Silver
AG
$8.05B
| $251K | ﹤0.01% |
+50,000
| New | +$279K |
|
3690
CALL
Theravance Biopharma
TBPH
$874M
| $251K | ﹤0.01% |
16,800
| – | – |
|
3691
Travelzoo
TZOO
$103M
| $251K | ﹤0.01% |
+19,876
| New | +$262K |
|
3692
Grupo Cibest SA
CIB
$20.4B
| $248K | ﹤0.01% |
5,172
-34,749
| -87% | -$1.85M |
|
3693
Ennis
EBF
$546M
| $248K | ﹤0.01% |
18,397
-7,789
| -30% | -$108K |
|
|
SRDX
3694
DELISTED
Surmodics
SRDX
| $246K | ﹤0.01% |
+11,149
| New | +$236K |
|
3695
Tenax Therapeutics
TENX
$385M
| $246K | ﹤0.01% |
2
| – | – |
|
|
UCTT
3696
Ultra Clean Holdings
UCTT
$4.16B
| $246K | ﹤0.01% |
26,475
+16,098
| +155% | +$136K |
|
3697
WIX.com
WIX
$2.15B
| $246K | ﹤0.01% |
+11,711
| New | +$223K |
|
|
TIVO
3698
CALL
DELISTED
TIVO INC
TIVO
| $246K | ﹤0.01% |
20,800
| – | – |
|
|
OSG
3699
PUT
Octave Specialty Group
OSG
$252M
| $245K | ﹤0.01% |
10,000
-28,400
| -74% | -$661K |
|
3700
Clorox
CLX
$11.6B
| $245K | ﹤0.01% |
+2,355
| New | +$235K |
|
Similar funds
D.E. Shaw & Co's Q4 2014 Portfolio in Review
As of Q4 2014, D.E. Shaw & Co held 4,575 positions worth $77.8B, up 0.73% from $77.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co's Q4 2014 filing shows 517 new, 1,382 increased, 1,468 reduced and 614 closed positions. Its largest new stake was James River Group Holdings: 14,047,238 shares worth $320M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.9% a quarter earlier, followed by Consumer Discretionary and Energy.
- D.E. Shaw & Co's largest Q4 2014 buy was James River Group Holdings: 14,047,238 shares worth $320M.
- D.E. Shaw & Co added most to IBM in Q4 2014, an estimated $339M increase.
- D.E. Shaw & Co's biggest Q4 2014 reduction was Apple, cutting an estimated $693M.
- D.E. Shaw & Co fully exited TIM HORTONS INC COM, CANADA in Q4 2014, selling an estimated $110M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $77.8B portfolio in Q4 2014.
- D.E. Shaw & Co opened 517 new positions and closed 614 in Q4 2014.
- D.E. Shaw & Co's portfolio value rose 0.73% quarter-over-quarter to $77.8B.
Based on D.E. Shaw & Co's 13F filing for Q4 2014, filed 17 Feb 2015.